Nine Masts Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-93,717
Closed -$9.52M 269
2025
Q4
$9.52M Buy
+93,717
New +$7.53M 1.64% 13
2019
Q3
Sell
-925
Closed -$109K 161
2019
Q2
$109K Sell
925
-3,289
-78% -$331K 0.02% 101
2019
Q1
$365K Buy
4,214
+1,881
+81% +$160K 0.11% 64
2018
Q4
$147K Buy
2,333
+908
+64% +$62.3K 0.02% 126
2018
Q3
$112K Buy
+1,425
New +$92.9K 0.03% 221
2018
Q2
Sell
-19,632
Closed -$792K 313
2018
Q1
$792K Buy
19,632
+13,365
+213% +$652K 0.12% 75
2017
Q4
$329K Buy
+6,267
New +$335K 0.04% 112

Other funds holding EXAS

Nine Masts Capital's EXAS Position: Q1 2026 in Review

Nine Masts Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 93,717 shares — an estimated $9.52M sold.

Nine Masts Capital first reported a position in EXAS in Q4 2017 and held it in 7 quarters. The position peaked at $9.52M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Nine Masts Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Nine Masts Capital sold 93,717 Exact Sciences shares in Q1 2026, an estimated $9.52M.
  • Nine Masts Capital first reported a position in Exact Sciences in Q4 2017 and held it in 7 quarters.
  • Nine Masts Capital's Exact Sciences position peaked at $9.52M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Nine Masts Capital's 13F filing for Q1 2026, filed 13 May 2026.